litlas
ログインアカウント作成

Mark G. Currie

1983–2024 年に発表

80
論文数
18,215
被引用数
69
h 指数
79
i10 指数

被引用数

Mark G. Currie の年別被引用数1972 年: 被引用 1 件1983 年: 被引用 9 件1984 年: 被引用 82 件1985 年: 被引用 138 件1986 年: 被引用 121 件1987 年: 被引用 52 件1988 年: 被引用 49 件1989 年: 被引用 33 件1990 年: 被引用 15 件1991 年: 被引用 13 件1992 年: 被引用 19 件1993 年: 被引用 31 件1994 年: 被引用 65 件1995 年: 被引用 113 件1996 年: 被引用 146 件1997 年: 被引用 166 件1998 年: 被引用 210 件1999 年: 被引用 167 件2000 年: 被引用 189 件2001 年: 被引用 188 件2002 年: 被引用 185 件2003 年: 被引用 154 件2004 年: 被引用 159 件2005 年: 被引用 113 件2006 年: 被引用 118 件2007 年: 被引用 105 件2008 年: 被引用 84 件2009 年: 被引用 82 件2010 年: 被引用 98 件2011 年: 被引用 99 件2012 年: 被引用 115 件2013 年: 被引用 85 件2014 年: 被引用 56 件2015 年: 被引用 66 件2016 年: 被引用 96 件2017 年: 被引用 74 件2018 年: 被引用 89 件2019 年: 被引用 201 件2020 年: 被引用 228 件2021 年: 被引用 236 件2022 年: 被引用 147 件2023 年: 被引用 99 件2024 年: 被引用 168 件2025 年: 被引用 64 件2026 年: 被引用 2 件1973〜1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,466 件、この内訳の 35.3%イギリス: 引用元論文 340 件、この内訳の 8.2%中国: 引用元論文 251 件、この内訳の 6.1%日本: 引用元論文 210 件、この内訳の 5.1%ドイツ: 引用元論文 205 件、この内訳の 4.9%イタリア: 引用元論文 197 件、この内訳の 4.8%カナダ: 引用元論文 167 件、この内訳の 4%オーストラリア: 引用元論文 109 件、この内訳の 2.6%フランス: 引用元論文 108 件、この内訳の 2.6%インド: 引用元論文 90 件、この内訳の 2.2%オランダ: 引用元論文 81 件、この内訳の 2%スペイン: 引用元論文 80 件、この内訳の 1.9%
0%35.3%その他 20.3%

機関

分野

  • Medicine64.8%
  • Biochemistry, Genetics and Molecular Biology17.3%
  • Neuroscience4.2%
  • Immunology and Microbiology3.7%
  • Agricultural and Biological Sciences2%
  • Chemistry1.9%
  • その他6.1%

トピック

  • Nitric Oxide and Endothelin Effects7.9%
  • Gastrointestinal motility and disorders3.6%
  • Inflammatory mediators and NSAID effects3%
  • Eicosanoids and Hypertension Pharmacology2.6%
  • Osteoarthritis Treatment and Mechanisms2.4%
  • Heart Failure Treatment and Management2.1%
  • その他78.4%

共著者

全論文

検索で開く
  1. Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

    著者: William D. Chey, Anthony Lembo, Bernard J. Lavins, Steven J. Shiff, Caroline B. Kurtz, Mark G. Currie, James E. MacDougall, Xinwei D. Jia, James Shao, Donald A. Fitch, Mollie Baird, Harvey Schneier, Jeffrey M. Johnston - The American Journal of Gastroenterology 2012 被引用: 451

  2. Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate

    著者: Joel Castro, Andrea M. Harrington, Patrick A. Hughes, Christopher M. Martin, Pei Ge, Courtney Shea, Hong Jin, Sarah Jacobson, Gerhard Hannig, Elizabeth A. Mann, Mitchell B. Cohen, James E. MacDougall, Bernard J. Lavins, Caroline B. Kurtz, Inmaculada Silos‐Santiago, Jeffrey M. Johnston, Mark G. Currie, L. Ashley Blackshaw, Stuart M. Brierley - Gastroenterology 2013 被引用: 294

  3. Two Randomized Trials of Linaclotide for Chronic Constipation

    著者: Anthony Lembo, Harvey Schneier, Steven J. Shiff, Caroline B. Kurtz, James E. MacDougall, Xinwei D. Jia, James Shao, Bernard J. Lavins, Mark G. Currie, Donald A. Fitch, Brenda I. Jeglinski, Paul Eng, Susan M. Fox, Jeffrey M. Johnston - New England Journal of Medicine 2011 被引用: 372

  4. A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

    著者: Satish S.C. Rao, Anthony Lembo, Steven J. Shiff, Bernard J. Lavins, Mark G. Currie, Xinwei D. Jia, Kelvin Shi, James E. MacDougall, James Shao, Paul Eng, Susan M. Fox, Harvey Schneier, Caroline B. Kurtz, Jeffrey M. Johnston - The American Journal of Gastroenterology 2012 被引用: 377

  5. Cyclooxygenase 2‐dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants

    著者: Medora M. Hardy, Karen Seibert, Pamela T. Manning, Mark G. Currie, B. Mark Woerner, Dorothy Edwards, Alane Koki, Catherine S. Tripp - Arthritis & Rheumatism 2002 被引用: 303

  6. Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

    著者: Robert Busby, Marco M. Kessler, Wilmin Bartolini, Alexander P. Bryant, Gerhard Hannig, Carolyn S. Higgins, Robert Solinga, Jenny Tobin, James Wakefield, Caroline B. Kurtz, Mark G. Currie - Journal of Pharmacology and Experimental Therapeutics 2012 被引用: 136

  7. Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

    著者: Philip Schoenfeld, Brian E. Lacy, William D. Chey, Anthony Lembo, Caroline B. Kurtz, David S. Reasner, Wieslaw Bochenek, Kenneth Tripp, Mark G. Currie, Susan M. Fox, Rick E. Blakesley, Christopher R. O'Dea, Nicholas Omniewski, Michael L. Hall - The American Journal of Gastroenterology 2017 被引用: 75

  8. An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension

    著者: John P. Hanrahan, Jelena Seferović, James Wakefield, Phebe Wilson, Jennifer Chickering, Joon Jung, Kenneth E. Carlson, Daniel P. Zimmer, Andrew L. Frelinger, Alan D. Michelson, Linda Morrow, Michael Hall, Mark G. Currie, G. Todd Milne, Albert T. Profy - Diabetologia 2019 被引用: 33

  9. Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

    著者: Robert Busby, Alexander P. Bryant, Wilmin Bartolini, Etchell A. Cordero, Gerhard Hannig, Marco M. Kessler, Shalina Mahajan‐Miklos, Christine M. Pierce, Robert Solinga, Li Jing Sun, Jenny Tobin, Caroline B. Kurtz, Mark G. Currie - European Journal of Pharmacology 2010 被引用: 248

  10. Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation

    著者: Jeffrey M. Johnston, Caroline B. Kurtz, James E. MacDougall, Bernard J. Lavins, Mark G. Currie, Donald A. Fitch, Chris OʼDea, Mollie Baird, Anthony Lembo - Gastroenterology 2010 被引用: 230

  11. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions

    著者: Yunsheng Yang, Yunsheng Yang, Jing‐Yuan Fang, Xiaozhong Guo, Ning Dai, Xizhong Shen, Youlin Yang, Youlin Yang, Jing Sun, Bal Raj Bhandari, David S. Reasner, Jacquelyn A. Cronin, Mark G. Currie, Jeffrey M. Johnston, Peter YF. Zeng, N Montreewasuwat, George Zhijian Chen, Sam Lim - Journal of Gastroenterology and Hepatology 2018 被引用: 80

  12. A Fluorometric Assay for the Measurement of Nitrite in Biological Samples

    著者: Thomas P. Misko, Roger Schilling, Daniela Salvemini, W. Michael Moore, Mark G. Currie - Analytical Biochemistry 1993 被引用: 1,023

  13. Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

    著者: Alexander P. Bryant, Robert Busby, Wilmin Bartolini, Etchell A. Cordero, Gerhard Hannig, Marco M. Kessler, Christine M. Pierce, Robert Solinga, Jenny Tobin, Shalina Mahajan‐Miklos, Mitchell B. Cohen, Caroline B. Kurtz, Mark G. Currie - Life Sciences 2010 被引用: 224

  14. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics

    著者: Trevor T. Hansel, Sergei A. Kharitonov, Louise Donnelly, Edward M. Erin, Mark G. Currie, William M. Moore, Pamela T. Manning, David P. Recker, Peter J. Barnes - The FASEB Journal 2003 被引用: 208

  15. Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cells

    著者: Guang Liu, Courtney Shea, Juli E. Jones, Gavrielle M. Price, William Warren, Elisabeth Lonie, Shu Yan, Mark G. Currie, Albert T. Profy, Jaime L. Masferrer, Daniel P. Zimmer - American Journal of Physiology-Renal Physiology 2020 被引用: 29

  16. Nitric oxide activates cyclooxygenase enzymes.

    著者: Daniela Salvemini, Thomas P. Misko, Jaime L. Masferrer, Karen Seibert, Mark G. Currie, Philip Needleman - National Academy of Sciences, Proceedings of the National Academy of Sciences 1993 被引用: 1,404

  17. Nitric oxide: a key mediator in the early and late phase of carrageenan‐induced rat paw inflammation

    著者: Daniela Salvemini, Zhiqiang Wang, Pamela S. Wyatt, David Bourdon, Margaret H. Marino, Pamela T. Manning, Mark G. Currie - British Journal of Pharmacology 1996 被引用: 670

  18. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase

    著者: Jean‐Pierre Pelletier, Dragan Jovanović, Julio Fernandes, Pamela T. Manning, Jane R. Connor, Mark G. Currie, John A. Di Battista, Johanne Martel‐Pelletier - Arthritis & Rheumatism 1998 被引用: 344

  19. Efficacy of Linaclotide for Patients With Chronic Constipation

    著者: Anthony Lembo, Caroline B. Kurtz, James E. MacDougall, Bernard J. Lavins, Mark G. Currie, Donald A. Fitch, Brenda I. Jeglinski, Jeffrey M. Johnston - Gastroenterology 2010 被引用: 235

  20. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial

    著者: Brian E. Lacy, Ron Schey, Steven J. Shiff, Bernard J. Lavins, Susan M. Fox, Xinwei D. Jia, Rick E. Blakesley, Xinming Hao, Jacquelyn A. Cronin, Mark G. Currie, Caroline B. Kurtz, Jeffrey M. Johnston, Anthony Lembo - PLoS ONE 2015 被引用: 81

  21. sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH

    著者: Katherine C. Hall, Sylvie G. Bernier, Sarah Jacobson, Guang Liu, Ping Y. Zhang, Renee Sarno, Victoria Catanzano, Mark G. Currie, Jaime L. Masferrer - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 被引用: 57

  22. Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease

    著者: John P. Hanrahan, Ian H. de Boer, George L. Bakris, Phebe Wilson, James Wakefield, Jelena P. Seferović, Jennifer Chickering, Yueh‐tyng Chien, Kenneth E. Carlson, Michael D. Cressman, Mark G. Currie, G. Todd Milne, Albert T. Profy - Clinical Journal of the American Society of Nephrology 2020 被引用: 40

  23. The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases

    著者: Susana S. Correia, Rajesh R. Iyengar, Peter Germano, Kim San Tang, Sylvie G. Bernier, Chad D. Schwartzkopf, Jenny Tobin, Thomas Lee, Guang Liu, Sarah Jacobson, Andrew Carvalho, Glen R. Rennie, Joon Jung, Paul A. Renhowe, Elisabeth Lonie, Christopher J. Winrow, John R. Hadcock, Juli E. Jones, Mark G. Currie - Frontiers in Pharmacology 2021 被引用: 36

  24. A Nonpeptidyl Mimic of Superoxide Dismutase with Therapeutic Activity in Rats

    著者: Daniela Salvemini, Zhiqiang Wang, Jay L. Zweíer, Alexandre Samouilov, Heather Macarthur, Thomas P. Misko, Mark G. Currie, Salvatore Cuzzocrea, James A. Sikorski, Dennis P. Riley - Science 1999 被引用: 499